Newron Pharmaceuticals
NWRN.SW
#8309
Rank
C$0.42 B
Marketcap
C$20.31
Share price
2.81%
Change (1 day)
77.73%
Change (1 year)

Earnings for Newron Pharmaceuticals (NWRN.SW)

Earnings in 2025: -C$20.48 Million

According to Newron Pharmaceuticals's latest financial reports the company's current earnings are C$22.46 Million. In 2025 the company made an earning of -C$20.48 Million a decrease over its 2024 earnings that were of C$31.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Newron Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025-C$20.48 Million-165.19%
2024C$31.4 M-224.32%
2023-C$25.27 Million-4.45%
2022-C$26.44 Million11.19%
2021-C$23.78 Million-30.14%
2020-C$34.04 Million6.84%
2019-C$31.86 Million31.45%
2018-C$24.24 Million170.13%
2017-C$8.98 Million-60.23%
2016-C$22.56 Million-41.46%
2015-C$38.54 Million109.46%
2014-C$18.4 Million22.43%
2013-C$15.03 Million222.49%
2012-C$4.66 Million-60.49%
2011-C$11.8 Million-71%
2010-C$40.67 Million-17.37%
2009-C$49.22 Million52.58%
2008-C$32.26 Million41.24%
2007-C$22.84 Million-25.19%
2006-C$30.53 Million22.45%
2005-C$24.93 Million